Pfizer saves 16,000 scientist hours annually and cuts infrastructure costs 55% with AWS generative AI for drug development

Pfizer's 1,500 pharmaceutical scientists spent excessive time on manual data discovery across fragmented repositories. The development of a single drug can generate approximately 20,000 documents, making it difficult to find historical data efficiently. The company also lacked internal bandwidth for rapid prototyping of new AI/ML solutions.

Through the Pfizer-Amazon Collaboration Team (PACT) initiative, Pfizer deployed Amazon Bedrock with Anthropic's Claude 2.1 for natural language search via voice command and chatbot on an internal platform called Vox. Amazon Kendra was developed to enable intelligent enterprise search across content repositories. A separate PCMM anomaly detection system was built using Amazon SageMaker, Amazon Lookout for Equipment, and Amazon Lookout for Metrics to monitor continuous pharmaceutical manufacturing.

Scientists can now save up to 16,000 hours of searching and extracting data annually. Infrastructure costs were reduced by 55%. Five of the 14 PACT prototypes have moved into production, and the initiative has spread innovation culture across multiple Pfizer groups and business lines.

• Rapid 6-week prototyping cycles (vs. 3+ months internally) enabled by a dedicated vendor collaboration team accelerate innovation without consuming internal engineering bandwidth.
• Generative AI applied to document-heavy scientific workflows can yield significant time savings at scale — 16,000 hours across 1,500 scientists.
• A structured "fail fast" prototype-to-MVP pipeline is effective for de-risking AI investments in regulated life sciences environments.